Genocea Biosciences, Inc. (GNCA) stock prices updated...
 

Genocea Biosciences, Inc. stock price

Genocea Biosciences, Inc. latest news:


  • 09/25/2017 15:57:28

    Genocea shares nearly halved on shift in drug development, layoffs

    Genocea Biosciences Inc. shares plummeted late Monday after the tiny Cambridge, Mass.-based biotech said it was shifting its drug development focus and cutting staff by 40%. Genocea shares dropped 49% to $2.72 after hours, following a brief halt. The company said it was halting spending and activities on its genital herpes treatment GEN-003, which was in late-stage clinical trials, and "exploring strategic alternatives" for the drug. Genocea said it was shifting its focus to cancer vaccines like GEN-009, which the company hopes to have in early-stage clinical trials in the first half of 2018. After the job cuts, which are expected to cost $1.1 million, Genocea expects to have about 55 employees.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Genomic Health, Inc.GHDX | Gentex CorporationGNTX | Gentherm IncTHRM | GenVec, Inc.GNVC | Georgetown Bancorp, Inc.GTWN | Geospace Technologies CorporationGEOS | German American Bancorp, Inc.GABC | Geron CorporationGERN | Gevo, Inc.GEVO | Gibraltar Industries, Inc.ROCK |